Clinical Trial Technology Editorial
-
The State of Real-World Data – And Where We Go From Here
12/7/2021
There are many questions that a lot of clinical executives have about real-world data (RWD) and real-world evidence. There are questions about the quality and completeness of the data, the new digital apps generating data, patient privacy, its use in synthetic control arms, and the impact it might have on the patient diversity problem.
-
Digitally Enabled Clinical Trials: A Practical Guide
12/2/2021
Undoubtedly, digital trials will stay as the world coexists with the pandemic, so it is essential for both sponsors and sites to be early adopters. This article will examine the benefits and challenges of digital clinical trials and identify key considerations for sponsors and sites as the world continues to navigate the new normal.
-
Clinical Trials Enter A New Digital Era
11/17/2021
The life sciences industry has been undergoing a transformation. Its seen advancements in how therapies are developed and improvements in how the industry works together. One development that has helped the industry evolve is the shift to digital technologies.
-
Our Lessons Learned In Implementing AI In Clinical Development
11/16/2021
Taiho Oncology had multiple sources of clinical data that weren't being leveraged to their fullest potential. When they implemented an AI-powered data analytics platform, they obtained a single source of truth for data analysis and reporting, and they learned a number of valuable process- and people-oriented lessons along the way.
-
Is A Decentralized Clinical Trial Right For Your Trial? & 5 Tips For Success
11/11/2021
Pharmaceutical companies have achieved considerable success in decentralizing clinical trials and shown that this model can offer significant benefits — both during the pandemic and afterward. While some elements of decentralization can be applied across all trial types, this article covers several specific trial characteristics that are particularly suited to remote studies, as well as tips to maximize success.
-
Report: Hybrid Clinical Trials Are Here To Stay
11/4/2021
ISR Reports has released a new report titled Hybrid/Virtual/Decentralized Clinical Trials Market Outlook. The report looks at the adoption of these trials and the components that are gaining the most traction.
-
Use Of Wearable And Sensor Applications In Clinical Trials Is Booming
10/26/2021
Experts predict 50% of clinical trials will incorporate wearables and sensors by 2025, compared to the 10 to 15% at present. This article shares market research on the use of wearables and sensors in clinical trials, including smartwatches, ingestible sensor-embedded pills, and more.
-
The Need For AI/ML In Drug Discovery, Dev, & Clinical Trials
10/25/2021
While an influx of new companies and technologies is spurring innovation in the industry, these startups are increasingly in competition for talent and capital. Although a fairly new area with respect to the use of AI, the drug design and development process is ripe for the application of machine learning and deep learning techniques.
-
Decentralized Trials Can Overcome The Challenges Of Rare Disease Patients
10/5/2021
There are 400 million people worldwide who are impacted by more than 7,000 identifiable rare diseases. While individual rare diseases are uncommon, approximately 5% of the world’s population suffers from one. A new report from technology provider THREAD details how many of the clinical challenges posed by rare disease trials can be alleviated by decentralized trials.
-
Decentralized Clinical Trials: Does Your Strategy Include These Facets?
9/30/2021
Decentralized clinical trials have increased in response to the COVID-19 pandemic, yet this may be due to a convergence of two factors already in play: our reliance on the use of digital health technologies and a move by the FDA and industry toward patient-focused, real-world clinical trials that leverage the technological advances already available.